Announced Wed, 17 Jun · 18:36 IST
Promoters confirm no share encumbrance created in FY26
Ownership Changes View source PDF
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹6.05
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.5-2.5-2.5-3.0-5.8-4.1-9.8-12.4——
Up moveDown movePending
AI summary
Promoter Santosh Varalwar, on behalf of all promoters of Vivimed Labs, has filed a declaration under SEBI takeover regulations confirming that no encumbrance such as pledge or lien was created on their shares during the financial year ended March 31, 2026.
Likely market impact
No new pledges or encumbrances by promoters in FY26, indicating no liquidity stress and continued confidence in the company.